NCT01759602View on ClinicalTrials.gov

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

PHASE1CompletedINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions

Neuromyelitis Optica

Interventions

DRUG

C1-esterase inhibitor (Cinryze)

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

ViroPharma

INDUSTRY

lead

Michael Levy

OTHER

NCT01759602 - C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation | Biotech Hunter | Biotech Hunter